Final analysis of KEYNOTE-A18 showed that pembrolizumab plus concurrent chemoradiation showed sustained PFS/OS benefits in ...

Consuming a noninflammatory diet increased OS for patients with late-stage colon cancer, according to findings from a large, ...

Less inflammatory diets were linked to improved overall survival in stage III colon cancer, and physical activity showed ...

New research suggests that an antibody-drug conjugate may offer practice-changing, patient-friendly treatment of blastic ...

At the ASMS 2025 conference, Sciex showcased its latest mass spectrometry system, the ZenoTOF 8600, along with updates to its ...

The cell therapy proved superior to standard-of-care regardless of cytogenetic risk or prior therapy in the CARTITUDE-4 study ...

Mia Scott hit a grand slam, Teagan Kavan claimed another win and Texas defeated Texas Tech 10-4 in Game 3 of the Women’s ...

President Donald Trump’s big bill in Congress would unleash trillions in tax cuts and slash spending, but also spike deficits ...

Adolescent and young adult (AYA) patients with acute lymphoblastic leukemia (ALL) face significant survival disparities and ...

"All couples fight, it's a given," says Kelley J. Brower. But don't make these toxic communication mistakes — here's what to ...

Minimal residual disease-negativity after treatment in DLBCL strongly correlates with remission and overall survival. However ...

In the Phase 1/1b trial, ficerafusp alfa in combination with pembrolizumab resulted in deep and durable anti-tumor activity with improved overall survival (OS) compared to historical benchmarks in ...